- 
				
Reduced Thalamic Nuclei Volume May Contribute to Anxiety in Parkinson’s Disease: a 7-Tesla MRI Study
 - 
				
Refining Aesthetic Eyebrows: Botulinum Toxin Injection for Hemifacial Spasm.
 - 
				
Refining and Understanding Causal Relationships between Brain Imaging-Derived Phenotypes and Parkinson’s Disease: a Bidirectional Mendelian Randomization Study and Clinical Validation
 - 
				
REGENERATE-PD: A Phase 2, Randomized, Double-Blind, Surgery-Controlled Study of GDNF Gene Therapy (AAV2-GDNF; AB-1005) for Moderate Stage Parkinson’s Disease
 - 
				
Regional Brain Volume Differences Across PD Clinical Subtypes
 - 
				
Regional tau burden patterns and their associations with clinical severity in progressive supranuclear palsy (PSP)-Richardson’s syndrome and PSP- predominant parkinsonism: a prospective cohort study
 - 
				
Relationship Between Non-Motor Symptoms, Kinematic Features, and Quality of Life in Cervical Dystonia
 - 
				
Relationships of blood Vitamin B12 and Homocysteine with Parkinson’s Disease Progression in 3 Contemporary Clinical Trials
 - 
				
Reliability and Validity of the English Version of the Parkinson Anxiety Scale
 - 
				
Reliability of Digital Measures in Parkinson’s Disease and Their Implications for Sample Size Calculations
 
- « Previous Page
 - 1
 - …
 - 139
 - 140
 - 141
 - 142
 - 143
 - …
 - 181
 - Next Page »
 
